Condition

Castrate Sensitive Prostate Cancer clinical trials and research

As of November 12, 2026, Find a Trial lists 3 Castrate Sensitive Prostate Cancer clinical trials that are recruiting, at sites in 2 countries (most in United States (2), Italy (1)). By phase: Phase 2 (1). Every study is explained in plain English. Data from ClinicalTrials.gov and NIH RePORTER, updated November 12, 2026.

Newest Castrate Sensitive Prostate Cancer clinical trials

StudyPhaseWhereStatusRegistered
Evaluating PSA response in metastatic prostate cancer — Rome, Lazio Recruiting Oct 22, 2024
Home-based exercise programs for men with metastatic prostate cancer — Charlottesville, Virginia Recruiting May 28, 2024
Abiraterone, Enzalutamide, or Apalutamide in Castration-sensitive Prostate Cancer Phase 2 Los Angeles, California and 11 other locations Recruiting Jun 21, 2022

All recruiting trials (3)

Related topics

Metastatic CancerMetastatic Prostate CancerProstate Cancer

Quick answers

How many Castrate Sensitive Prostate Cancer clinical trials are recruiting right now?

3, as of November 12, 2026. We update this list each time we refresh our data from ClinicalTrials.gov.

Where are these trials running?

In 2 countries. The most sites are in United States (2 trials), Italy (1 trial). Each study page lists its sites and which ones are recruiting.

What phases are they in?

Phase 2: 1. Trials with no phase listed are usually device, behavioural or observational studies.

How do I join one?

Open a study, check the "Is this trial a fit for you?" section, then contact the study team listed on the page. They will ask a few screening questions. Asking is free and does not commit you to anything. Talk it over with your doctor first.

Find the studies that fit you

A list is a starting point. Tell us your situation in your own words and we'll rank the studies that match and explain why. It's free and needs no account.

Describe your situation →

Last reviewed 2026-11-12 by the Find a Trial editorial team. Information on this page is for educational purposes and is not medical advice. Always consult qualified healthcare professionals about clinical trial participation.